| Full text | |
| Author(s): |
Total Authors: 2
|
| Affiliation: | [1] University of São Paulo. School of Pharmaceutical Sciences of Ribeirão Preto - Brasil
[2] University of São Paulo. School of Pharmaceutical Sciences of Ribeirão Preto - Brasil
Total Affiliations: 2
|
| Document type: | Journal article |
| Source: | Brazilian Journal of Pharmaceutical Sciences; v. 59, 2023-05-08. |
| Abstract | |
Abstract Currently, mucosal vaccine administration has stood out as an easier and non-invasive application method. It can also be used to induce local and systemic immune responses. In the COVID-19 pandemic context, nasal and oral vaccines have been developed based on different technological platforms. This review addressed relevant aspects of mucosal vaccine administration, with emphasis on oral and nasal vaccinations, in addition to the importance of using nanotechnology-based delivery systems to enable these strategies. (AU) | |
| FAPESP's process: | 19/08891-8 - The use of ferritin nanoparticles as a basis for the development of antitumor vaccine delivery systems |
| Grantee: | Fabiana Testa Moura de Carvalho Vicentini |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 19/25548-5 - Development and characterization of ferritin nanoparticles for DNA vaccine delivery |
| Grantee: | Natália Floriano Paiva |
| Support Opportunities: | Scholarships in Brazil - Scientific Initiation |